AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. (ANTX) — SEC Financial Statements & Analysis
AN2 Therapeutics, Inc. (ANTX) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 53 | 20 | 18 | 18 | 20 | 21 | 34 | 27 | 25 | 16 | 33 | 41 | |||||
Available For Sale Securities Debt Securities Curr… | 32 | 38 | 44 | 45 | 47 | 62 | 60 | 78 | 90 | 92 | 91 | 54 | |||||
Prepaid Expense And Other Assets Current | 2 | 2 | 2 | 5 | 2 | 3 | 4 | 3 | 2 | 3 | 3 | 3 | |||||
Assets Current | 87 | 60 | 64 | 68 | 70 | 86 | 98 | 107 | 116 | 111 | 126 | 98 | |||||
Available For Sale Securities Debt Securities Nonc… | 0 | 2 | 3 | 8 | 11 | 5 | - | - | 4 | 27 | 26 | - | |||||
Other Assets Noncurrent | - | 0 | 0 | 0 | 0 | 1 | - | 1 | 1 | 1 | 1 | 1 | |||||
Assets | 87 | 62 | 67 | 76 | 81 | 92 | 98 | 108 | 121 | 139 | 154 | 99 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 3 | 3 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 3 | 5 | 3 | |||||
Employee Related Liabilities Current | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 1 | 4 | 2 | 2 | |||||
Accrued Liabilities Current | 2 | 2 | 3 | 3 | 4 | 4 | 5 | 6 | 7 | 7 | 7 | 6 | |||||
Operating Lease Liability Current | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Other Liabilities Current | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | - | |||||
Liabilities Current | 6 | 9 | - | - | - | 10 | 10 | - | - | 14 | 15 | 11 | |||||
Other Liabilities Noncurrent | 0 | 0 | - | - | - | 0 | - | - | - | - | - | - | |||||
Liabilities | 6 | 9 | 7 | 7 | 8 | 10 | 10 | 10 | 11 | 14 | 15 | 11 | |||||
Stockholders Equity | |||||||||||||||||
Additional Paid In Capital | 333 | 294 | 293 | 292 | 290 | 288 | 286 | 284 | 282 | 279 | 277 | 209 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | -0 | |||||
Retained Earnings Accumulated Deficit | -251 | -241 | -232 | -223 | -216 | -206 | -198 | -186 | -171 | -154 | -138 | -121 | |||||
Stockholders Equity | 82 | 53 | 60 | 69 | 73 | 82 | 88 | 98 | 111 | 125 | 139 | 88 | |||||
Liabilities And Stockholders Equity | 87 | 62 | 67 | 76 | 81 | 92 | 98 | 108 | 121 | 139 | 154 | 99 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | |||||
Common Stock Shares Issued | 36 | 27 | 27 | 27 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 22 | |||||
Shares Outstanding | 36 | 27 | 27 | 27 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 22 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -19.07% | -6.36% | - | - | - | - | - | - | - | - | - | - |
| 2025 | -4.24% | -11.02% | -10.17% | 20.00% | 23.81% | 17.14% | -6.78% | -5.93% | -4.24% | -40.60% | -10.80% | -23.60% |
| 2024 | -12.12% | 13.85% | 11.69% | -6.42% | -1.83% | -0.92% | 42.57% | 40.59% | 12.87% | -16.00% | -19.33% | -28.67% |
| 2023 | - | - | - | 81.55% | 91.43% | 72.98% | 9.03% | 33.05% | 26.62% | - | - | - |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data